SSG
LH icon

Summit Securities Group’s Labcorp LH Stock Holding History

Summit Securities Group’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.32K Buy
19
+5
+36% +$1.31K ﹤0.01% 965
2026
Q1 		$3.73K Sell
14
-108
-89% -$29.2K ﹤0.01% 847
2025
Q4 		$30.6K Sell
122
-23
-16% -$6.11K ﹤0.01% 720
2025
Q3 		$41.6K Buy
145
+89
+159% +$23.8K 0.01% 610
2025
Q2 		$14.7K Buy
+56
New +$13.6K ﹤0.01% 803
2023
Q3 		– Sell
-135
Closed -$28K – 820
2023
Q2 		$28K Sell
135
-68
-33% -$13.2K ﹤0.01% 551
2023
Q1 		$40K Buy
203
+98
+93% +$20.2K ﹤0.01% 472
2022
Q4 		$21K Buy
105
+85
+425% +$16.6K ﹤0.01% 894
2022
Q3 		$3K Sell
20
-206
-91% -$42.2K ﹤0.01% 849
2022
Q2 		$45K Buy
226
+182
+414% +$38.8K 0.01% 578
2022
Q1 		$10K Buy
+44
New +$10.3K ﹤0.01% 840
2015
Q4 		– Sell
-19
Closed -$2K – 376
2015
Q3 		$2K Buy
+19
New +$1.97K ﹤0.01% 310

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Summit Securities Group's LH Position: Q2 2026 in Review

Summit Securities Group increased its Labcorp (LH) stake by 36% in Q2 2026, buying an estimated $1.31K and bringing the position to 19 shares worth $5.32K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

Summit Securities Group first reported a position in LH in Q3 2015 and has held it in 12 quarters since. The position peaked at $45K in Q2 2022. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Summit Securities Group held 19 shares of Labcorp worth $5.32K as of Q2 2026.
  • Summit Securities Group bought 5 Labcorp shares in Q2 2026, an estimated $1.31K.
  • Labcorp made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #965 holding.
  • Summit Securities Group first reported a position in Labcorp in Q3 2015 and has held it in 12 quarters since.
  • Summit Securities Group's Labcorp position peaked at $45K in Q2 2022.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.